Predictive Oncology EBITDA Margin 2010-2025 | POAI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Predictive Oncology (POAI) over the last 10 years. The current EBITDA margin for Predictive Oncology as of June 30, 2025 is .
| Predictive Oncology EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.00B | $-0.01B | -800.00% |
| 2025-03-31 | $0.00B | $-0.01B | -800.00% |
| 2024-12-31 | $0.00B | $-0.01B | -900.00% |
| 2024-09-30 | $0.00B | $-0.01B | 0.00% |
| 2024-06-30 | $0.00B | $-0.01B | -900.00% |
| 2024-03-31 | $0.00B | $-0.01B | -1100.00% |
| 2023-12-31 | $0.00B | $-0.01B | -1100.00% |
| 2023-09-30 | $0.00B | $-0.02B | -2200.00% |
| 2023-06-30 | $0.00B | $-0.02B | 0.00% |
| 2023-03-31 | $0.00B | $-0.02B | 0.00% |
| 2022-12-31 | $0.00B | $-0.02B | 0.00% |
| 2022-09-30 | $0.00B | $-0.02B | 0.00% |
| 2022-06-30 | $0.00B | $-0.02B | 0.00% |
| 2022-03-31 | $0.00B | $-0.02B | 0.00% |
| 2021-12-31 | $0.00B | $-0.02B | 0.00% |
| 2021-09-30 | $0.00B | $-0.02B | 0.00% |
| 2021-06-30 | $0.00B | $-0.02B | 0.00% |
| 2021-03-31 | $0.00B | $-0.02B | 0.00% |
| 2020-12-31 | $0.00B | $-0.02B | 0.00% |
| 2020-09-30 | $0.00B | $-0.01B | 0.00% |
| 2020-06-30 | $0.00B | $-0.01B | -1100.00% |
| 2020-03-31 | $0.00B | $-0.01B | -1200.00% |
| 2019-12-31 | $0.00B | $-0.01B | -1100.00% |
| 2019-09-30 | $0.00B | $-0.01B | -1100.00% |
| 2019-06-30 | $0.00B | $-0.01B | 0.00% |
| 2019-03-31 | $0.00B | $-0.01B | 0.00% |
| 2018-12-31 | $0.00B | $-0.01B | 0.00% |
| 2018-09-30 | $0.00B | $-0.01B | 0.00% |
| 2018-06-30 | $0.00B | $-0.01B | 0.00% |
| 2018-03-31 | $0.00B | $-0.01B | 0.00% |
| 2017-12-31 | $0.00B | $-0.01B | 0.00% |
| 2017-09-30 | $0.00B | $-0.01B | 0.00% |
| 2017-06-30 | $0.00B | $-0.01B | 0.00% |
| 2017-03-31 | $0.00B | $-0.01B | 0.00% |
| 2016-12-31 | $0.00B | $-0.01B | 0.00% |
| 2016-09-30 | $0.00B | $-0.01B | 0.00% |
| 2016-06-30 | $0.00B | $-0.01B | 0.00% |
| 2016-03-31 | $0.00B | $-0.01B | 0.00% |
| 2015-12-31 | $0.00B | $0.00B | 0.00% |
| 2015-09-30 | $0.00B | $0.00B | 0.00% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| 2015-03-31 | $0.00B | $-0.01B | 0.00% |
| 2014-12-31 | $0.00B | $-0.01B | 0.00% |
| 2014-09-30 | $0.00B | $-0.01B | 0.00% |
| 2014-06-30 | $0.00B | $-0.01B | 0.00% |
| 2014-03-31 | $0.00B | $-0.01B | 0.00% |
| 2013-12-31 | $0.00B | $-0.01B | 0.00% |
| 2013-09-30 | $0.00B | $-0.01B | 0.00% |
| 2013-06-30 | $0.00B | $-0.01B | 0.00% |
| 2013-03-31 | $0.00B | $-0.01B | 0.00% |
| 2012-12-31 | $0.00B | $-0.01B | 0.00% |
| 2012-09-30 | $0.00B | $-0.01B | 0.00% |
| 2012-06-30 | $0.00B | $-0.01B | 0.00% |
| 2012-03-31 | $0.00B | $-0.01B | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.976B | 58.72 |
| Doximity (DOCS) | United States | $12.734B | 56.66 |
| Tempus AI (TEM) | United States | $12.722B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.947B | 81.50 |
| IRhythm Technologies (IRTC) | United States | $5.455B | 0.00 |
| Hinge Health (HNGE) | United States | $4.531B | 0.00 |
| Heartflow (HTFL) | $2.821B | 0.00 | |
| Inspire Medical Systems (INSP) | United States | $2.730B | 40.13 |
| Privia Health (PRVA) | United States | $2.669B | 197.73 |
| Phreesia (PHR) | United States | $1.904B | 0.00 |
| Enovis (ENOV) | United States | $1.773B | 9.37 |
| 10x Genomics (TXG) | United States | $1.745B | 0.00 |
| Omnicell (OMCL) | United States | $1.526B | 29.41 |
| Schrodinger (SDGR) | United States | $1.457B | 0.00 |
| Azenta (AZTA) | United States | $1.384B | 60.40 |
| Clover Health Investments (CLOV) | United States | $1.379B | 0.00 |
| Claritev (CTEV) | United States | $1.184B | 0.00 |
| Evolent Health (EVH) | United States | $1.130B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.542B | 0.00 |
| Veradigm (MDRX) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.489B | 0.00 |
| Talkspace (TALK) | United States | $0.454B | 135.50 |
| Butterfly Network (BFLY) | United States | $0.395B | 0.00 |
| Carlsmed (CARL) | United States | $0.369B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 52.95 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| Outset Medical (OM) | United States | $0.248B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.225B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.210B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| CapsoVision (CV) | United States | $0.185B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.157B | 7.13 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.085B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.071B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.040B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| PROFUSA (PFSA) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |